Likewise, impaired function of the upstream transcription factor NPAT has also been demonstrated in a variety of aggressive cancers, including Hodgkin’s lymphoma, colorectal cancers, and breast cancers [129-131]. The gene discussed is NPAT; the disease is breast carcinoma.